PharmaFluidics

    OverviewSuggest Edit

    Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.
    TypePrivate
    Founded2010
    HQGhent, BE
    Websitepharmafluidics.com

    Latest Updates

    Employees (est.) (Sep 2019)21(+5%)

    Key People/Management at PharmaFluidics

    Johan Devenyns

    Johan Devenyns

    CEO

    PharmaFluidics Office Locations

    PharmaFluidics has an office in Ghent
    Show all (1)

    PharmaFluidics Financials and Metrics

    Summary Metrics

    Founding Date

    2010

    Time since last funding

    5 years ago

    PharmaFluidics investors

    Show all financial metrics

    PharmaFluidics Online and Social Media Presence

    Embed Graph

    PharmaFluidics Blogs

    Watch our webinar on demand – Double your IDs for single cell proteomics using micro Pillar Array Columns (µPAC™)

    In this webinar, Karl Mechtler head of the VBCF mass-spectrometer pool and the IMP/IMBA/GMI mass-spectrometry Facility Vienna, will present record protein identification data generated with PharmaFluidics’ µPAC™ columns for single-cell proteomics analysis. Geert Van Raemdonck, Global Field Support E…

    PharmaFluidics introduces its µPAC™ Trapping column

    Ghent, Belgium – February 1, 2019 – PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way of performing separations by creating nano-LC columns on a silicon chip. Their µPAC™ columns enable a robust and highly reprod…

    Perfecting Proteomics Separations

    The Analytical Scientist interviewed Prof Kris Gevaert and Dr Francis Impens about their work in proteomics and how our µPAC™ technology can improve proteomic analyses. The post Perfecting Proteomics Separations appeared first on PharmaFluidics.

    Webinar – Expanding the Limits of Shotgun Proteomics Using Micro Pillar Array Columns and Data-Independant Acquisition (DIA) Methods

    In this webcast, Dr. Jeff Op de Beeck, the application development manager of PharmaFluidics, will explain specific features of the micro-chip-based pillar array chromatography and Dr. Jan Muntel, a senior scientist at Biognosys AG, will report on the latest application of PharmaFluidics' nanoflow c…

    How Engineers Developed a Disruptive Technology to Separate Samples

    SelectScience interviewed our COO and Co-Founder Dr. Paul Jacobs. The post How Engineers Developed a Disruptive Technology to Separate Samples appeared first on PharmaFluidics.

    PharmaFluidics Facilitates Ultra-high-resolution Proteomics Analysis Through Agreement with Thermo Fisher Scientific

    Ghent, Belgium – September 30, 2018 – PharmaFluidics NV, an innovative bio-analytical chromatography company, announced today that it entered into a Partnership Agreement with Thermo Fisher Scientific Inc, a global Life Sciences Tools and Instruments leader. The agreement empowers PharmaFluidics to …
    Show more

    PharmaFluidics Frequently Asked Questions

    • When was PharmaFluidics founded?

      PharmaFluidics was founded in 2010.

    • Who are PharmaFluidics key executives?

      PharmaFluidics's key executives are Johan Devenyns.

    • How many employees does PharmaFluidics have?

      PharmaFluidics has 21 employees.

    • Who are PharmaFluidics competitors?

      Competitors of PharmaFluidics include Quartzy, Axcella Health and Schrodinger.

    • Where are PharmaFluidics offices?

      PharmaFluidics has an office in Ghent.

    • How many offices does PharmaFluidics have?

      PharmaFluidics has 1 office.